Menu

Topics

Connect

Comments

Comments closed.

Due to the sensitive and/or legal subject matter of some of the content on globalnews.ca, we reserve the ability to disable comments from time to time.

Please see our Commenting Policy for more.

NACI preference for mRNA COVID-19 vaccine triggers concern

In the wake of NACI expressing its preference for Pfizer and Moderna, some have accused the advisory council of contributing to confusion and inconsistent messaging around vaccines. Shallima Maharaj reports.

Advertisement

More Videos

Advertisement

You are viewing an Accelerated Mobile Webpage.

View Original Article